Serotonergic agents in the treatment of disorders of anxiety and impulse control.

Impulse control disorders in non-treatment seeking hair pullers.

Impulse control disorders in elderly patients.

Impulse control disorders and "behavioural addictions" in the ICD-11.

Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.

Impulse control disorders in frontotemporal dementia: spectrum of symptoms and response to treatment.

Clinical spectrum of impulse control disorders in Parkinson's disease.

Treatment of anxiety disorders.

Impulse control and related disorders in Mexican Parkinson's disease patients.

Bipolar disorder and comorbid obsessive-compulsive disorder is associated with higher rates of anxiety and impulse control disorders.

Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease.

Dopamine receptor agonist drugs and impulse control disorders.

Treatment of pediatric anxiety disorders.

Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Family-based interventions for the prevention of substance abuse and other impulse control disorders in girls.

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?

The diagnosis of and treatment recommendations for anxiety disorders.

A survey of impulse control disorders in Parkinson's disease patients in Shanghai area and literature review.

Assessment and treatment of anxiety disorders in children and adolescents.

Pharmacologic Treatment of Pediatric Anxiety Disorders.

Evidence-based treatment of anxiety disorders.

Anxiety disorders: causes, diagnosis and treatment.

Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.

Acute serotonergic treatment changes the relation between anxiety and HPA-axis functioning and periaqueductal gray activation.

Diagnosis and treatment of child and adolescent anxiety disorders.

Suggest Documents

Impulse control disorders in non-treatment seeking hair pullers.

Impulse control disorders in elderly patients.

Impulse control disorders and "behavioural addictions" in the ICD-11.

Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.

Impulse control disorders in frontotemporal dementia: spectrum of symptoms and response to treatment.

Clinical spectrum of impulse control disorders in Parkinson's disease.

Treatment of anxiety disorders.

Impulse control and related disorders in Mexican Parkinson's disease patients.

Bipolar disorder and comorbid obsessive-compulsive disorder is associated with higher rates of anxiety and impulse control disorders.

Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease.

Dopamine receptor agonist drugs and impulse control disorders.

Treatment of pediatric anxiety disorders.

Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Family-based interventions for the prevention of substance abuse and other impulse control disorders in girls.

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?

The diagnosis of and treatment recommendations for anxiety disorders.

A survey of impulse control disorders in Parkinson's disease patients in Shanghai area and literature review.

Assessment and treatment of anxiety disorders in children and adolescents.

Pharmacologic Treatment of Pediatric Anxiety Disorders.

Evidence-based treatment of anxiety disorders.

Anxiety disorders: causes, diagnosis and treatment.

Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.

Acute serotonergic treatment changes the relation between anxiety and HPA-axis functioning and periaqueductal gray activation.

Diagnosis and treatment of child and adolescent anxiety disorders.

Serotonergic agents in the treatment of disorders of anxiety and impulse control.

Recommend Documents

Follow Us